|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/57 | (2006.01) |
| A61K 47/69 | (2017.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/08 | (2006.01) |
| (11) | Number of the document | 2806877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13740743.3 |
| Date of filing the European patent application | 2013-01-23 | |
| (97) | Date of publication of the European application | 2014-12-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation | 2019-12-10 |
| (86) | Number | PCT/US2013/022772 |
| Date | 2013-01-23 |
| (87) | Number | WO 2013/112605 |
| Date | 2013-08-01 |
| (30) | Number | Date | Country code |
| 201261589740 P | 2012-01-23 | US |
| (72) |
REDDY, Kiran, US
|
| (73) |
Sage Therapeutics, Inc. ,
55 Cambridge Parkway, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neuroaktyvios steroidų kompozicijos, apimančios alopregnanolono ir sulfobutilo eterio beta-ciklodekstrino kompleksą |
| NEUROACTIVE STEROID FORMULATIONS COMPRISING A COMPLEX OF ALLOPREGNANOLONE AND SULFOBUTYL ETHER BETA-CYCLODEXTRIN |
| Payment date | Validity (years) | Amount | |
| 2025-01-02 | 13 | 289.00 EUR |
| 2026-01-23 |